Key statistics
On Thursday, Apollomics Inc (APLM:NAQ) closed at 0.101, 25.62% above the 52 week low of 0.0804 set on Nov 15, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.12 |
---|---|
High | 0.1225 |
Low | 0.0959 |
Bid | 0.10 |
Offer | 0.1058 |
Previous close | 0.1498 |
Average volume | 173.11m |
---|---|
Shares outstanding | 110.27m |
Free float | 58.38m |
P/E (TTM) | -- |
Market cap | 11.14m USD |
EPS (TTM) | -0.568 USD |
Data delayed at least 15 minutes, as of Nov 21 2024 21:00 GMT.
More ▼
- Apollomics’ Announces Shareholder Approval and Effective Date for 1-for-100 Reverse Share Split
- Apollomics Presents Vebreltinib Data in Patients with Non-Small Cell Lung Cancer with METex14 Skipping Mutations at European Society for Medical Oncology (ESMO) Congress 2024
- Apollomics to Present at the H.C. Wainwright 26th Annual Global Investment Conference
- Apollomics Reports First Half 2024 Financial Results and Highlights Vebreltinib Clinical Progress
- Apollomics Announces Positive Preliminary Data of Vebreltinib in Patients with Non-CNS MET Fusion Solid Tumors from its Phase 2 SPARTA Trial
- Apollomics to Present at the Canaccord Genuity 44th Annual Growth Conference
- Apollomics Granted 180-Day Extension to Regain Compliance with Nasdaq Minimum Bid Price Requirement
- Apollomics Announces Updated Strategic Focus and Leadership Team Changes
- Apollomics Announces Vebreltinib Data at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
- Apollomics Announces Presentation at the 2024 BIO International Convention
More ▼